Aurinia Pharmaceuticals Inc.
AUPH
$7.12
-$0.475-6.26%
Corporate Info
Website
Phone Number
250-744-2487
Address
#140, 14315 – 118 Avenue
Edmonton, AB T5L 4S6
Edmonton, AB T5L 4S6
Country
Canada
Year Founded
1993
Details
Sector
Health Care
Industry
Pharmaceuticals, Biotechnology and Life Sciences
Employees
130
Business Decription
Aurinia Pharmaceuticals Inc., a biopharmaceutical company, focuses on delivering therapies to treat autoimmune diseases with unmet medical needs in the United States. It offers LUPKYNIS (voclosporin), an oral therapy for the treatment of adult patients with active lupus nephritis. The company also develops AUR200, a dual inhibitor of B cell activating factor and a proliferation inducing ligand for the potential treatment of autoimmune diseases. It has a collaboration and license agreement with Otsuka Pharmaceutical Co., Ltd. The company was incorporated in 1993 and is headquartered in Edmonton, Canada.